Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
OTC Markets
ETFs
Canadian ETFs
US ETFs
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
News Focus
TRILLION ENERGY’S WEST AKCAKOCA WELL ENTERS PRODUCTION (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Satellos Bioscience Inc Ordinary Shares
V.MSCL
Alternate Symbol(s):
ICOTF
Healthcare
Biotechnology
Satellos Bioscience Inc is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle...
regeneration in severe disorders. Its lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:MSCL)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(82)
•••
bmreed
X
Post by
bmreed
on Mar 14, 2023 2:46pm
Business Update: CTO Phil Lambert Discusses SAT-3153 Results
Business Update: Satellos Bioscience $MSCL with CTO Philip Lambert - https://youtu.be/OZAfLhS9WB4 Chief Technology Officer Phil Lambert Discusses SAT-3153 Study Results
...more
(435)
•••
G1945V
X
Comment by
G1945V
on Feb 17, 2023 1:09pm
RE:Zacks-Fireside Chat With Frank Gleeson-02/13/2023
Zacks - Small-Cap Research - Outlook - David Bautz PhD https://s27.q4cdn.com/906368049/files/News/2023/Zacks_SCR_Research_02072023_MSCLF_Bautz.pdf G1945V
Numinus Launches a Complete Psychedelic-Assisted Therapy Training Program
posted Mar 28, 2023 9:00am by
Numinus Wellness Inc.
-
|
The Certification Pathway develops core PAT skills through multi-modal teaching methods including interactive evidence and theory reviews, audio-visual design, case-based learning, experiential learning, in-person shadowing opportunities, and more. Once all course requirements in the Certification Pathway are completed, trained practitioners will receive a formal certificate from Numinus to designate competency in providing PAT using specific medicines. ...read more
(435)
•••
G1945V
X
Post by
G1945V
on Feb 17, 2023 12:47pm
Zacks-Fireside Chat With Frank Gleeson-02/13/2023
A Fireside Chat With Frank Gleeson, MBA - Co-Founder, CEO, And Board Member Of Satellos Bioscience Price Target 70 cents US https://scr.zacks.com/news/news-details/2023/A-Fireside-Chat-with-Frank
...more
(435)
•••
G1945V
X
Post by
G1945V
on Feb 06, 2023 8:20am
News Story Feb 6 2023
Satellos Bioscience Announces Significant Increase in Muscle Size and Function in Duchenne Muscular Dystrophy Disease Model G1945V
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 03, 2022 7:51am
New Press Release - Satellos Bioscience Announces Advancement of Compounds to Next Stage of Development
-Proof of concept studies to be completed by YE-Toronto, Ontario--(Newsfile Corp. - November 3, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a drug discovery company developing therapeutics to regenerate muscle as a new approach to treating disease conditions from...
read article.
(10)
•••
Drambuey
X
Post by
Drambuey
on Nov 01, 2022 5:35pm
.012 pre consolidation
KEEP UP THE GOOD WORK azz CLOWNS
(82)
•••
bmreed
X
Post by
bmreed
on Oct 24, 2022 10:30am
Video Recap - $MSCL CEO Frank Gleeson & CTO Phil Lambert
Webinar Recap: Satellos Bioscience (MSCL) w CEO Frank Gleeson and CTO Phil Lambert - Pitch, Deep Dive and Q&A - https://youtu.be/n2DKT55G1pk CEO Frank Gleeson and CTO Phil Lambert
...more
(435)
•••
G1945V
X
Comment by
G1945V
on Oct 18, 2022 1:59pm
RE:Webinar w $MSCL CEO Frank Gleeson - Tue Oct 18 @ 1PM ET
I just caught the last 10 minutes. Was anything new said outside of elaborating on the prospectus? Will a replay be available? TIA G1945V
(82)
•••
bmreed
X
Post by
bmreed
on Oct 14, 2022 2:06pm
Webinar w $MSCL CEO Frank Gleeson - Tue Oct 18 @ 1PM ET
Webinar - Satellos Bioscience Inc. $MSCL w/ CEO Frank Gleeson Tue, October 18 at 1pm ET / 10am PT Q&A with Radius Research Register Here - https://us02web.zoom.us/webinar/register
...more
(10)
•••
Drambuey
X
Post by
Drambuey
on Oct 13, 2022 3:14pm
.30 = .015 pre consolidation
Keep up the good work azz clowns management bonuses all around
(0)
•••
PressRelease
X
Post by
PressRelease
on Sep 28, 2022 7:31am
New Press Release - Satellos Bioscience Inc. Announces the Appointment of Philip D. Lambert, Ph.D, as Chief Technology Officer
Toronto, Ontario--(Newsfile Corp. - September 28, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change the way degenerative muscle diseases are treated, is pleased to announce that its board of...
read article.
(10)
•••
Drambuey
X
Post by
Drambuey
on Sep 13, 2022 11:32pm
.35 = 0175 preconsolidation
Good job azz clowns
(0)
•••
PressRelease
X
Post by
PressRelease
on Sep 13, 2022 9:07am
New Press Release - Satellos Bioscience Inc. Announces Closing of Offering of Units
Toronto, Ontario--(Newsfile Corp. - September 13, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change the way degenerative muscle diseases are treated, is pleased to announce the closing of its...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Sep 07, 2022 4:02pm
New Press Release - Satellos Bioscience Inc. Announces the Filing of Final Short Form Prospectus for Proposed Offering of Units
Toronto, Ontario--(Newsfile Corp. - September 7, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change the way degenerative muscle diseases are treated, announced today that it has filed its final...
read article.
(598)
•••
beenthere
X
Comment by
beenthere
on Sep 05, 2022 4:35pm
RE:And this one!
Negative that's why!!
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Herald Price Sensitive
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}}
{{story.headline}}
< Previous bulletin
Next bulletin >
The Power Play by The Market Herald
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video
{{moreVideoText}}
Next Video >
Featured News Links
This Silver Producer Outperformed Peers in Q4 and Looks Strong for 2023
ESG Dynamo Scores Big Again with Record Q4 and YE 2022 Results
Well-funded Mineral Exploration Company Focused on Exploring Economically Viable Mineral Deposits
Clean Energy VS. Renewable Energy, Which is Better and Why? Download Insights Report Here